Pfizer announced today results of a survey the company recently
sponsored that shows physicians are more likely to report side effects
through an electronic health records (EHR) system, as compared to
traditional paper methods. Nearly 60 percent of physicians who responded
to the survey also agreed that adverse event reporting through an EHR
system would improve patient care.
“Patient safety continues to be a top priority at Pfizer,” said Freda
Lewis-Hall, MD, Pfizer’s chief medical officer. “This survey furthers
our understanding about how we can best use electronic health records
systems to collect critical information about the safe and appropriate
use of our products so that we can improve patient safety.”
Of the 300 physicians surveyed, two-thirds utilized some form of an EHR
system and one-third used a paper-based system. Half of all respondents
and 60 percent of fully-functional EHR users reported that they would be
much more likely to submit information about adverse events using an EHR
system. Of those still using paper-based systems, 80 percent cited cost
as a deterrent to investing in an EHR system.
Ipsos conducted the survey online among primary care physicians in the
United States who were categorized as basic electronic health record
users, fully functional electronic health record users or paper health
record users. The research was conducted during September and October
2009.
As part of the company’s ongoing efforts to improve patient safety,
Pfizer is collaborating with Brigham and Women’s Hospital, Partners
Healthcare, CDISC, an international standards group, and CRIX
International to improve the quality of data in safety reports. Earlier
this year, the group conducted a pilot known as the ASTER (Adverse Drug
Event Spontaneous Triggered Event Reporting) study, allowing physicians
to use electronic health records to report adverse events directly to
the Food and Drug Administration (FDA). By exploring a combination of
standards, technology and a new business model, the group intends to
help physicians better recognize and report adverse events.
“These survey results confirm what we saw in the Partners Healthcare
ASTER study,” said Jeffrey A. Linder, MD, MPH, FACP an internist at
Brigham and Women's Hospital in Boston. “The system we used in that
study was well accepted by the participating physicians, who felt the
adverse event reporting was unobtrusive and who saw the public health
potential of this type of reporting. While most of the participating
clinicians submitted no reports in the year prior to the study, they
submitted hundreds of detailed reports during the five months of the
study period."
Interesting and somewhat surprising, not that providers prefer and electronic method for submitting ADE reports, but that providers saw the tool as "unobtrusive."
As the FDA hones in on a pharmacovigilance strategy, they should certainly consider standardizing integration with EHRs (or make it a requirement for vendors).